ONTOLOGY REPORT - ANNOTATIONS
| Term: | hydroquinone |
|
| Accession: | CHEBI:17594
|
browse the term
|
| Definition: | Aromatic compound comprising benzene core carrying two hydroxy substituents para to each other. |
| Synonyms: | related_synonym: | 1,4-Benzenediol; 1,4-Dihydroxybenzene; 4-Hydroxyphenol; Benzene-1,4-diol; C6H6O2; Eldoquin; InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H; InChIKey=QIGBRXMKCJKVMJ-UHFFFAOYSA-N; Oc1ccc(O)cc1; Quinol; p-Benzenediol; p-hydroxyphenol |
| | alt_id: | CHEBI:14416; CHEBI:24645; CHEBI:5793 |
| | xref_casrn: | 123-31-9 |
| | xref: | Beilstein:605970 "Beilstein Registry Number"; ChEBI:c0091 "UM-BBD compID"; ChEMBL:113329 "ChEMBL COMPOUND"; ChemIDplus:123-31-9 "CAS Registry Number"; CiteXplore:1395635 "PubMed citation"; Gmelin:2742 "Gmelin Registry Number"; KEGG COMPOUND:123-31-9 "CAS Registry Number"; KEGG COMPOUND:C00530 "KEGG COMPOUND" |
| | xref_mesh: | MESH:C031927 |
| | xref: | NIST Chemistry WebBook:123-31-9 "CAS Registry Number"; Wikipedia:Hydroquinone "Wikipedia" |
|
|
hydroquinone
|
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
ISO |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects localization |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
affects expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bora |
bora, aurora kinase A activator |
|
decreases expression |
ISO |
15 |
82,829,209 |
82,852,061 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
decreases expression |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases cleavage |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
decreases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
decreases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
decreases expression |
ISO |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
decreases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects response to substance |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
affects response to substance |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
multiple interactions |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
affects expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
decreases expression |
ISO |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
affects expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
increases expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
decreases expression |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Fam83d |
family with sequence similarity 83, member D |
|
decreases expression |
ISO |
3 |
149,504,288 |
149,523,556 |
RGD:6480464 |
CTD |
| G |
Fbxo5 |
F-box protein 5 |
|
decreases expression |
ISO |
1 |
36,492,134 |
36,498,503 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
affects expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
decreases expression |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
multiple interactions |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
decreases expression |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
multiple interactions |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
affects localization |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
multiple interactions |
ISO |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hist1h1b |
histone cluster 1, H1b |
|
decreases expression |
ISO |
17 |
50,360,616 |
50,361,284 |
RGD:6480464 |
CTD |
| G |
Hist1h1d |
histone cluster 1, H1d |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hist1h2ai |
histone cluster 1, H2ai |
|
decreases expression |
ISO |
17 |
50,352,763 |
50,353,155 |
RGD:6480464 |
CTD |
| G |
Hist1h3c |
histone cluster 1, H3c |
|
decreases expression |
ISO |
17 |
48,514,749 |
48,515,222 |
RGD:6480464 |
CTD |
| G |
Hist2h2aa3 |
histone cluster 2, H2aa3 |
|
decreases expression |
ISO |
2 |
191,052,007 |
191,052,604 |
RGD:6480464 |
CTD |
| G |
Hist2h2ab |
histone cluster 2, H2ab |
|
decreases expression |
ISO |
2 |
191,022,967 |
191,023,359 |
RGD:6480464 |
CTD |
| G |
Hist2h2ac |
histone cluster 2, H2ac |
|
decreases expression |
ISO |
2 |
191,023,502 |
191,023,891 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
multiple interactions |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
ISO |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
increases expression |
ISO |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hyls1 |
hydrolethalus syndrome 1 |
|
decreases expression |
ISO |
8 |
35,345,398 |
35,354,440 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
decreases cleavage |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases cleavage |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
multiple interactions |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases activity |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
decreases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
decreases expression |
ISO |
3 |
125,181,063 |
125,216,481 |
RGD:6480464 |
CTD |
| G |
Kif18a |
kinesin family member 18A |
|
decreases expression |
ISO |
3 |
94,825,019 |
94,885,158 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
increases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
increases expression |
ISO |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
multiple interactions |
ISO |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
affects expression |
ISO |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
LOC680322 |
similar to Histone H2A type 1 |
|
decreases expression |
ISO |
17 |
50,119,480 |
50,119,866 |
RGD:6480464 |
CTD |
| G |
LOC680430 |
similar to germinal histone H4 gene |
|
decreases expression |
ISO |
17 |
50,339,068 |
50,339,460 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
decreases expression |
ISO |
18 |
67,281,440 |
67,348,558 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp15 |
matrix metallopeptidase 15 |
|
affects expression |
ISO |
19 |
10,122,553 |
10,143,853 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
affects expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpl |
myeloproliferative leukemia virus oncogene |
|
increases expression |
ISO |
5 |
138,921,281 |
138,931,990 |
RGD:6480464 |
CTD |
| G |
Mpl |
myeloproliferative leukemia virus oncogene |
|
decreases methylation |
ISO |
5 |
138,921,281 |
138,931,990 |
RGD:6480464 |
CTD |
| G |
Mpl |
myeloproliferative leukemia virus oncogene |
|
multiple interactions |
ISO |
5 |
138,921,281 |
138,931,990 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases oxidation |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
multiple interactions |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
decreases degradation |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
affects expression |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
increases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pgls |
6-phosphogluconolactonase |
|
affects expression |
ISO |
16 |
18,791,241 |
18,796,727 |
RGD:6480464 |
CTD |
| G |
Polh |
polymerase (DNA directed), eta |
|
increases response to substance |
ISO |
9 |
10,341,975 |
10,375,983 |
RGD:6480464 |
CTD |
| G |
Polh |
polymerase (DNA directed), eta |
|
multiple interactions |
ISO |
9 |
10,341,975 |
10,375,983 |
RGD:6480464 |
CTD |
| G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
|
increases expression |
ISO |
10 |
73,575,506 |
73,612,063 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
increases expression |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Recql4 |
RecQ protein-like 4 |
|
increases expression |
ISO |
7 |
114,752,863 |
114,760,027 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
increases expression |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
increases expression |
ISO |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spi1 |
spleen focus forming virus (SFFV) proviral integration oncogene spi1 |
|
increases phosphorylation |
ISO |
3 |
75,456,353 |
75,475,722 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
increases expression |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
decreases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
decreases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
increases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf12 |
tumor necrosis factor ligand superfamily member 12 |
|
decreases expression |
ISO |
10 |
56,503,756 |
56,513,053 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
affects activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
increases expression |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
increases expression |
ISO |
19 |
35,073,150 |
35,075,251 |
RGD:6480464 |
CTD |
| G |
Traf4 |
Tnf receptor associated factor 4 |
|
decreases expression |
ISO |
10 |
64,471,018 |
64,477,122 |
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
decreases expression |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
increases activity |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
multiple interactions |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
increases response to substance |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
multiple interactions |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
multiple interactions |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
decreases response to substance |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
| G |
Wrn |
Werner syndrome, RecQ helicase-like |
|
decreases response to substance |
ISO |
16 |
62,535,144 |
62,668,700 |
RGD:6480464 |
CTD |
hydroquinone O-beta-D-glucopyranoside
|
| G |
Abca13 |
ATP-binding cassette, subfamily A (ABC1), member 13 |
|
decreases expression |
ISO |
14 |
89,714,129 |
90,226,523 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
decreases expression |
ISO |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
decreases expression |
ISO |
7 |
139,873,596 |
139,884,675 |
RGD:6480464 |
CTD |
| G |
Adam19 |
ADAM metallopeptidase domain 19 |
|
decreases expression |
ISO |
10 |
31,190,242 |
31,282,773 |
RGD:6480464 |
CTD |
| G |
Adam20 |
ADAM metallopeptidase domain 20 |
|
decreases expression |
ISO |
16 |
39,654,619 |
39,662,865 |
RGD:6480464 |
CTD |
| G |
Adam7 |
ADAM metallopeptidase domain 7 |
|
increases expression |
ISO |
15 |
48,184,131 |
48,232,533 |
RGD:6480464 |
CTD |
| G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
|
decreases expression |
ISO |
14 |
19,756,887 |
19,963,451 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases expression |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
decreases expression |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Aebp2 |
AE binding protein 2 |
|
increases expression |
ISO |
4 |
177,821,215 |
177,876,673 |
RGD:6480464 |
CTD |
| G |
Afap1 |
actin filament associated protein 1 |
|
decreases expression |
ISO |
14 |
80,355,358 |
80,448,224 |
RGD:6480464 |
CTD |
| G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
|
decreases expression |
ISO |
20 |
10,720,044 |
10,751,589 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
decreases expression |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Amtn |
amelotin |
|
decreases expression |
ISO |
14 |
21,231,281 |
21,243,840 |
RGD:6480464 |
CTD |
| G |
Ankrd17 |
ankyrin repeat domain 17 |
|
increases expression |
ISO |
14 |
19,273,617 |
19,387,067 |
RGD:6480464 |
CTD |
| G |
Ankrd23 |
ankyrin repeat domain 23 |
|
increases expression |
ISO |
9 |
35,472,715 |
35,479,314 |
RGD:6480464 |
CTD |
| G |
Ap1s1 |
adaptor-related protein complex 1, sigma 1 subunit |
|
decreases expression |
ISO |
12 |
20,907,855 |
20,918,301 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
increases expression |
ISO |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
Aptx |
aprataxin |
|
decreases expression |
ISO |
5 |
58,060,210 |
58,081,165 |
RGD:6480464 |
CTD |
| G |
Arfip2 |
ADP-ribosylation factor interacting protein 2 |
|
decreases expression |
ISO |
1 |
163,364,860 |
163,369,542 |
RGD:6480464 |
CTD |
| G |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
|
decreases expression |
ISO |
2 |
180,748,313 |
180,775,656 |
RGD:6480464 |
CTD |
| G |
Arl2 |
ADP-ribosylation factor-like 2 |
|
decreases expression |
ISO |
1 |
208,909,458 |
208,921,401 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
ISO |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Arx |
aristaless related homeobox |
|
decreases expression |
ISO |
X |
80,631,375 |
80,643,989 |
RGD:6480464 |
CTD |
| G |
Asna1 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
|
decreases expression |
ISO |
19 |
24,786,390 |
24,794,477 |
RGD:6480464 |
CTD |
| G |
Atf6b |
activating transcription factor 6 beta |
|
decreases expression |
ISO |
20 |
4,192,185 |
4,200,036 |
RGD:6480464 |
CTD |
| G |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
|
decreases expression |
ISO |
1 |
201,260,278 |
201,271,175 |
RGD:6480464 |
CTD |
| G |
Bag5 |
BCL2-associated athanogene 5 |
|
decreases expression |
ISO |
6 |
136,491,438 |
136,495,093 |
RGD:6480464 |
CTD |
| G |
Bcas2 |
breast carcinoma amplified sequence 2 |
|
increases expression |
ISO |
2 |
198,405,211 |
198,413,092 |
RGD:6480464 |
CTD |
| G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
decreases expression |
ISO |
1 |
187,189,665 |
187,194,336 |
RGD:6480464 |
CTD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
decreases expression |
ISO |
2 |
239,727,569 |
239,767,802 |
RGD:6480464 |
CTD |
| G |
Bnip2 |
BCL2/adenovirus E1B interacting protein 2 |
|
increases expression |
ISO |
8 |
74,421,904 |
74,435,300 |
RGD:6480464 |
CTD |
| G |
Brsk1 |
BR serine/threonine kinase 1 |
|
decreases expression |
ISO |
1 |
67,851,020 |
67,876,360 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
decreases expression |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Bzrap1 |
benzodiazapine receptor (peripheral) associated protein 1 |
|
decreases expression |
ISO |
10 |
76,053,461 |
76,074,635 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
decreases expression |
ISO |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
|
decreases expression |
ISO |
1 |
64,114,233 |
64,140,485 |
RGD:6480464 |
CTD |
| G |
Capns2 |
calpain, small subunit 2 |
|
increases expression |
ISO |
19 |
15,193,882 |
15,194,824 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cbx6 |
chromobox homolog 6 |
|
decreases expression |
ISO |
7 |
118,062,267 |
118,070,004 |
RGD:6480464 |
CTD |
| G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
|
increases expression |
ISO |
20 |
29,997,000 |
30,039,602 |
RGD:6480464 |
CTD |
| G |
Ccdc170 |
coiled-coil domain containing 170 |
|
decreases expression |
ISO |
1 |
35,196,779 |
35,290,683 |
RGD:6480464 |
CTD |
| G |
Ccnyl1 |
cyclin Y-like 1 |
|
increases expression |
ISO |
9 |
63,316,278 |
63,377,369 |
RGD:6480464 |
CTD |
| G |
Cct8 |
chaperonin containing Tcp1, subunit 8 (theta) |
|
increases expression |
ISO |
11 |
27,233,711 |
27,245,369 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
decreases expression |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd160 |
CD160 molecule |
|
decreases expression |
ISO |
2 |
191,611,172 |
191,619,320 |
RGD:6480464 |
CTD |
| G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
|
decreases expression |
ISO |
1 |
186,451,415 |
186,455,407 |
RGD:6480464 |
CTD |
| G |
Cd3g |
CD3 molecule, gamma |
|
decreases expression |
ISO |
8 |
47,924,369 |
47,930,550 |
RGD:6480464 |
CTD |
| G |
Cdk16 |
cyclin-dependent kinase 16 |
|
decreases expression |
ISO |
X |
12,910,972 |
12,916,939 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Clec4b2 |
C-type lectin domain family 4, member B2 |
|
decreases expression |
ISO |
4 |
159,745,231 |
159,769,388 |
RGD:6480464 |
CTD |
| G |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
|
decreases expression |
ISO |
X |
58,198,352 |
58,440,335 |
RGD:6480464 |
CTD |
| G |
Col17a1 |
collagen, type XVII, alpha 1 |
|
decreases expression |
ISO |
1 |
253,012,167 |
253,059,385 |
RGD:6480464 |
CTD |
| G |
Cpb1 |
carboxypeptidase B1 (tissue) |
|
decreases expression |
ISO |
2 |
105,413,336 |
105,443,909 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpne5 |
copine V |
|
increases expression |
ISO |
20 |
7,453,643 |
7,535,366 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
increases expression |
ISO |
2 |
228,771,187 |
228,788,636 |
RGD:6480464 |
CTD |
| G |
Ddx46 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
|
increases expression |
ISO |
17 |
14,985,633 |
15,029,607 |
RGD:6480464 |
CTD |
| G |
Diaph2 |
diaphanous homolog 2 (Drosophila) |
|
decreases expression |
ISO |
X |
116,641,770 |
117,258,314 |
RGD:6480464 |
CTD |
| G |
Dlgap4 |
discs, large (Drosophila) homolog-associated protein 4 |
|
increases expression |
ISO |
3 |
147,081,222 |
147,176,024 |
RGD:6480464 |
CTD |
| G |
Dlx1 |
distal-less homeobox 1 |
|
decreases expression |
ISO |
3 |
53,837,052 |
53,841,642 |
RGD:6480464 |
CTD |
| G |
Dmxl1 |
Dmx-like 1 |
|
decreases expression |
ISO |
18 |
44,819,576 |
44,828,508 |
RGD:6480464 |
CTD |
| G |
Dnah7 |
dynein, axonemal, heavy chain 7 |
|
decreases expression |
ISO |
9 |
52,217,861 |
52,520,698 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dpp7 |
dipeptidylpeptidase 7 |
|
decreases expression |
ISO |
3 |
3,514,968 |
3,519,220 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
decreases expression |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
increases expression |
ISO |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
|
increases expression |
ISO |
8 |
25,173,429 |
25,286,246 |
RGD:6480464 |
CTD |
| G |
Efhc2 |
EF-hand domain (C-terminal) containing 2 |
|
decreases expression |
ISO |
X |
16,981,096 |
17,181,453 |
RGD:6480464 |
CTD |
| G |
Efna3 |
ephrin A3 |
|
decreases expression |
ISO |
2 |
181,454,410 |
181,508,170 |
RGD:6480464 |
CTD |
| G |
Efs |
embryonal Fyn-associated substrate |
|
decreases expression |
ISO |
15 |
33,018,805 |
33,028,147 |
RGD:6480464 |
CTD |
| G |
Eftud1 |
elongation factor Tu GTP binding domain containing 1 |
|
increases expression |
ISO |
1 |
138,920,620 |
139,044,342 |
RGD:6480464 |
CTD |
| G |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
|
increases expression |
ISO |
3 |
112,979,189 |
112,980,908 |
RGD:6480464 |
CTD |
| G |
Elane |
elastase, neutrophil expressed |
|
decreases expression |
ISO |
7 |
11,329,642 |
11,331,490 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
decreases expression |
ISO |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
decreases expression |
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
increases expression |
ISO |
4 |
174,601,291 |
174,672,247 |
RGD:6480464 |
CTD |
| G |
Epx |
eosinophil peroxidase |
|
increases expression |
ISO |
10 |
76,160,005 |
76,171,089 |
RGD:6480464 |
CTD |
| G |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
|
increases expression |
ISO |
4 |
155,931,377 |
156,221,104 |
RGD:6480464 |
CTD |
| G |
Exd1 |
exonuclease 3'-5' domain containing 1 |
|
decreases expression |
ISO |
3 |
106,038,460 |
106,066,302 |
RGD:6480464 |
CTD |
| G |
F13b |
coagulation factor XIII, B polypeptide |
|
decreases expression |
ISO |
13 |
52,867,851 |
52,889,426 |
RGD:6480464 |
CTD |
| G |
Fam3d |
family with sequence similarity 3, member D |
|
decreases expression |
ISO |
15 |
18,520,414 |
18,554,410 |
RGD:6480464 |
CTD |
| G |
Fam49b |
family with sequence similarity 49, member B |
|
increases expression |
ISO |
7 |
101,150,480 |
101,275,452 |
RGD:6480464 |
CTD |
| G |
Fancd2os |
FANCD2 opposite strand |
|
decreases expression |
ISO |
4 |
149,500,797 |
149,504,275 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbxo11 |
F-box protein 11 |
|
increases expression |
ISO |
6 |
11,542,561 |
11,566,829 |
RGD:6480464 |
CTD |
| G |
Fbxo16 |
F-box protein 16 |
|
increases expression |
ISO |
15 |
44,690,042 |
44,736,309 |
RGD:6480464 |
CTD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
decreases expression |
ISO |
14 |
12,713,971 |
12,734,634 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fpgt |
fucose-1-phosphate guanylyltransferase |
|
decreases expression |
ISO |
2 |
252,878,847 |
252,885,883 |
RGD:6480464 |
CTD |
| G |
Fras1 |
Fraser syndrome 1 |
|
decreases expression |
ISO |
14 |
14,309,668 |
14,574,022 |
RGD:6480464 |
CTD |
| G |
Frmpd4 |
FERM and PDZ domain containing 4 |
|
decreases expression |
ISO |
X |
47,683,734 |
47,814,085 |
RGD:6480464 |
CTD |
| G |
Galc |
galactosylceramidase |
|
increases expression |
ISO |
6 |
122,355,659 |
122,416,986 |
RGD:6480464 |
CTD |
| G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
|
decreases expression |
ISO |
19 |
26,165,658 |
26,177,206 |
RGD:6480464 |
CTD |
| G |
Glt8d2 |
glycosyltransferase 8 domain containing 2 |
|
decreases expression |
ISO |
7 |
23,265,829 |
23,299,748 |
RGD:6480464 |
CTD |
| G |
Gmpr |
guanosine monophosphate reductase |
|
decreases expression |
ISO |
17 |
25,147,730 |
25,185,385 |
RGD:6480464 |
CTD |
| G |
Gnl2 |
guanine nucleotide binding protein-like 2 (nucleolar) |
|
increases expression |
ISO |
5 |
144,373,848 |
144,399,235 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
decreases expression |
ISO |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
increases expression |
ISO |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gpr155 |
G protein-coupled receptor 155 |
|
decreases expression |
ISO |
3 |
55,846,337 |
55,900,086 |
RGD:6480464 |
CTD |
| G |
Gpr26 |
G protein-coupled receptor 26 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpr55 |
G protein-coupled receptor 55 |
|
decreases expression |
ISO |
9 |
84,657,975 |
84,658,934 |
RGD:6480464 |
CTD |
| G |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
|
decreases expression |
ISO |
4 |
172,027,523 |
172,039,757 |
RGD:6480464 |
CTD |
| G |
Gsdma |
gasdermin A |
|
decreases expression |
ISO |
10 |
87,439,818 |
87,452,308 |
RGD:6480464 |
CTD |
| G |
Gucy1a2 |
guanylate cyclase 1, soluble, alpha 2 |
|
decreases expression |
ISO |
8 |
113,253 |
262,544 |
RGD:6480464 |
CTD |
| G |
Hand1 |
heart and neural crest derivatives expressed 1 |
|
increases expression |
ISO |
10 |
43,423,366 |
43,425,933 |
RGD:6480464 |
CTD |
| G |
Hist1h1a |
histone cluster 1, H1a |
|
increases expression |
ISO |
17 |
48,526,427 |
48,527,170 |
RGD:6480464 |
CTD |
| G |
Hoxb8 |
homeo box B8 |
|
decreases expression |
ISO |
10 |
85,013,711 |
85,015,462 |
RGD:6480464 |
CTD |
| G |
Hps3 |
Hermansky-Pudlak syndrome 3 homolog (human) |
|
decreases expression |
ISO |
2 |
105,135,644 |
105,177,925 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
ISO |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
|
increases expression |
ISO |
X |
141,697,471 |
141,711,652 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
decreases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
|
decreases expression |
ISO |
8 |
69,391,326 |
69,405,309 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
decreases expression |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il3ra |
interleukin 3 receptor, alpha |
|
increases expression |
ISO |
12 |
16,825,702 |
16,830,035 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
decreases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Ina |
internexin neuronal intermediate filament protein, alpha |
|
decreases expression |
ISO |
1 |
252,328,186 |
252,340,997 |
RGD:6480464 |
CTD |
| G |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
|
increases expression |
ISO |
19 |
27,722,430 |
28,363,639 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnab3 |
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
|
decreases expression |
ISO |
10 |
56,119,461 |
56,126,544 |
RGD:6480464 |
CTD |
| G |
Kctd17 |
potassium channel tetramerisation domain containing 17 |
|
decreases expression |
ISO |
7 |
116,379,781 |
116,390,554 |
RGD:6480464 |
CTD |
| G |
Kdelc1 |
KDEL (Lys-Asp-Glu-Leu) containing 1 |
|
increases expression |
ISO |
9 |
43,194,771 |
43,207,358 |
RGD:6480464 |
CTD |
| G |
Kif26b |
kinesin family member 26B |
|
decreases expression |
ISO |
13 |
94,184,947 |
94,606,719 |
RGD:6480464 |
CTD |
| G |
Klhl13 |
kelch-like family member 13 |
|
increases expression |
ISO |
X |
10,344,050 |
10,424,665 |
RGD:6480464 |
CTD |
| G |
Lctl |
lactase-like |
|
decreases expression |
ISO |
8 |
68,316,883 |
68,334,752 |
RGD:6480464 |
CTD |
| G |
LOC100361700 |
proline rich region 18-like |
|
decreases expression |
ISO |
1 |
47,040,962 |
47,043,972 |
RGD:6480464 |
CTD |
| G |
LOC100361913 |
rCG54286-like |
|
decreases expression |
ISO |
1 |
84,383,795 |
84,384,760 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
decreases expression |
ISO |
1 |
206,102,750 |
206,206,350 |
RGD:6480464 |
CTD |
| G |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
|
decreases expression |
ISO |
4 |
171,337,114 |
171,444,932 |
RGD:6480464 |
CTD |
| G |
Lrrc4 |
leucine rich repeat containing 4 |
|
decreases expression |
ISO |
4 |
55,698,248 |
55,701,844 |
RGD:6480464 |
CTD |
| G |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
|
decreases expression |
ISO |
4 |
114,142,055 |
114,940,958 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
decreases expression |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Map4k5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
|
decreases expression |
ISO |
6 |
91,885,447 |
91,978,735 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mcm8 |
minichromosome maintenance complex component 8 |
|
increases expression |
ISO |
3 |
120,614,429 |
120,644,673 |
RGD:6480464 |
CTD |
| G |
Mdfi |
MyoD family inhibitor |
|
decreases expression |
ISO |
9 |
8,623,038 |
8,641,388 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
decreases expression |
ISO |
10 |
47,646,157 |
47,649,095 |
RGD:6480464 |
CTD |
| G |
Midn |
midnolin |
|
decreases expression |
ISO |
7 |
11,061,651 |
11,068,365 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmgt1 |
membrane magnesium transporter 1 |
|
increases expression |
ISO |
X |
141,123,953 |
141,136,288 |
RGD:6480464 |
CTD |
| G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
decreases expression |
ISO |
1 |
34,759,445 |
34,800,865 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
decreases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Myo3b |
myosin IIIB |
|
decreases expression |
ISO |
3 |
52,249,255 |
52,645,911 |
RGD:6480464 |
CTD |
| G |
Ncald |
neurocalcin delta |
|
decreases expression |
ISO |
7 |
72,875,314 |
72,976,373 |
RGD:6480464 |
CTD |
| G |
Negr1 |
neuronal growth regulator 1 |
|
decreases expression |
ISO |
2 |
254,666,633 |
255,426,378 |
RGD:6480464 |
CTD |
| G |
Neu4 |
sialidase 4 |
|
increases expression |
ISO |
9 |
93,150,680 |
93,156,336 |
RGD:6480464 |
CTD |
| G |
Nkd1 |
naked cuticle homolog 1 (Drosophila) |
|
decreases expression |
ISO |
19 |
19,759,537 |
19,832,877 |
RGD:6480464 |
CTD |
| G |
Nmi |
N-myc (and STAT) interactor |
|
increases expression |
ISO |
3 |
32,962,021 |
32,996,031 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
increases expression |
ISO |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nrp2 |
neuropilin 2 |
|
increases expression |
ISO |
9 |
61,348,529 |
61,460,457 |
RGD:6480464 |
CTD |
| G |
Ntf4 |
neurotrophin 4 |
|
decreases expression |
ISO |
1 |
95,885,577 |
95,888,408 |
RGD:6480464 |
CTD |
| G |
Olfml1 |
olfactomedin-like 1 |
|
decreases expression |
ISO |
1 |
164,953,064 |
164,977,360 |
RGD:6480464 |
CTD |
| G |
Osbp2 |
oxysterol binding protein 2 |
|
decreases expression |
ISO |
14 |
84,350,465 |
84,511,727 |
RGD:6480464 |
CTD |
| G |
Osbpl11 |
oxysterol binding protein-like 11 |
|
increases expression |
ISO |
11 |
69,356,220 |
69,418,534 |
RGD:6480464 |
CTD |
| G |
Otx1 |
orthodenticle homeobox 1 |
|
decreases expression |
ISO |
14 |
102,721,413 |
102,724,748 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
decreases expression |
ISO |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
increases expression |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Pcgf6 |
polycomb group ring finger 6 |
|
increases expression |
ISO |
1 |
252,357,987 |
252,377,545 |
RGD:6480464 |
CTD |
| G |
Pcmtd2 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
|
increases expression |
ISO |
3 |
170,995,554 |
171,014,586 |
RGD:6480464 |
CTD |
| G |
Pcnxl2 |
pecanex-like 2 (Drosophila) |
|
decreases expression |
ISO |
19 |
55,957,098 |
56,012,859 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
decreases expression |
ISO |
2 |
191,643,593 |
191,675,995 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
decreases expression |
ISO |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Pgm2 |
phosphoglucomutase 2 |
|
increases expression |
ISO |
14 |
46,827,166 |
46,862,298 |
RGD:6480464 |
CTD |
| G |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
|
decreases expression |
ISO |
10 |
15,188,278 |
15,204,292 |
RGD:6480464 |
CTD |
| G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
decreases expression |
ISO |
8 |
19,669,537 |
19,681,741 |
RGD:6480464 |
CTD |
| G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
|
increases expression |
ISO |
12 |
45,386,041 |
45,434,744 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
decreases expression |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
increases expression |
ISO |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Pphln1 |
periphilin 1 |
|
increases expression |
ISO |
7 |
131,866,854 |
131,958,060 |
RGD:6480464 |
CTD |
| G |
Prg2 |
proteoglycan 2, bone marrow |
|
decreases expression |
ISO |
3 |
68,209,731 |
68,213,293 |
RGD:6480464 |
CTD |
| G |
Prkx |
protein kinase, X-linked |
|
decreases expression |
ISO |
X |
63,484,553 |
63,533,858 |
RGD:6480464 |
CTD |
| G |
Prmt2 |
protein arginine methyltransferase 2 |
|
decreases expression |
ISO |
20 |
12,800,400 |
12,817,018 |
RGD:6480464 |
CTD |
| G |
Prr18 |
proline rich 18 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Prrx1 |
paired related homeobox 1 |
|
decreases expression |
ISO |
13 |
78,961,648 |
79,028,882 |
RGD:6480464 |
CTD |
| G |
Prss2 |
protease, serine, 2 |
|
decreases expression |
ISO |
4 |
69,088,288 |
69,093,312 |
RGD:6480464 |
CTD |
| G |
Psmd13 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
decreases expression |
ISO |
1 |
201,044,403 |
201,057,026 |
RGD:6480464 |
CTD |
| G |
Psmd3 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 |
|
decreases expression |
ISO |
10 |
87,456,442 |
87,468,383 |
RGD:6480464 |
CTD |
| G |
Rab6b |
RAB6B, member RAS oncogene family |
|
decreases expression |
ISO |
8 |
108,151,061 |
108,192,013 |
RGD:6480464 |
CTD |
| G |
Rasgef1b |
RasGEF domain family, member 1B |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1304931 |
similar to RIKEN cDNA 2310042D19 |
|
decreases expression |
ISO |
5 |
173,050,659 |
173,055,952 |
RGD:6480464 |
CTD |
| G |
RGD1310371 |
similar to RIKEN cDNA 1700026D08 |
|
decreases expression |
ISO |
1 |
140,036,327 |
140,061,890 |
RGD:6480464 |
CTD |
| G |
RGD1560146 |
similar to hypothetical protein MGC34837 |
|
decreases expression |
ISO |
5 |
116,864,803 |
116,932,065 |
RGD:6480464 |
CTD |
| G |
RGD1563680 |
similar to CDNA sequence BC052040 |
|
increases expression |
ISO |
3 |
101,607,751 |
101,811,485 |
RGD:6480464 |
CTD |
| G |
Rnf208 |
ring finger protein 208 |
|
decreases expression |
ISO |
3 |
3,408,497 |
3,409,821 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
increases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rsbn1 |
round spermatid basic protein 1 |
|
decreases expression |
ISO |
2 |
199,146,161 |
199,200,110 |
RGD:6480464 |
CTD |
| G |
Saa4 |
serum amyloid A4, constitutive |
|
decreases expression |
ISO |
1 |
97,278,427 |
97,282,729 |
RGD:6480464 |
CTD |
| G |
Sccpdh |
saccharopine dehydrogenase (putative) |
|
increases expression |
ISO |
13 |
95,349,783 |
95,371,537 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
increases expression |
ISO |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
decreases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
decreases expression |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Serpina5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
|
decreases expression |
ISO |
6 |
128,156,901 |
128,161,334 |
RGD:6480464 |
CTD |
| G |
Serpind1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
|
decreases expression |
ISO |
11 |
85,666,714 |
85,677,716 |
RGD:6480464 |
CTD |
| G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
increases expression |
ISO |
9 |
53,796,176 |
53,837,297 |
RGD:6480464 |
CTD |
| G |
Sfrp5 |
secreted frizzled-related protein 5 |
|
decreases expression |
ISO |
1 |
248,652,323 |
248,656,785 |
RGD:6480464 |
CTD |
| G |
Sh3gl2 |
SH3-domain GRB2-like 2 |
|
decreases expression |
ISO |
5 |
104,129,280 |
104,308,317 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
decreases expression |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc15a3 |
solute carrier family 15, member 3 |
|
decreases expression |
ISO |
1 |
213,341,322 |
213,356,103 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc23a3 |
solute carrier family 23 (nucleobase transporters), member 3 |
|
increases expression |
ISO |
9 |
74,409,051 |
74,417,617 |
RGD:6480464 |
CTD |
| G |
Slc25a2 |
solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2 |
|
decreases expression |
ISO |
18 |
30,536,488 |
30,537,684 |
RGD:6480464 |
CTD |
| G |
Slc27a4 |
solute carrier family 27 (fatty acid transporter), member 4 |
|
decreases expression |
ISO |
3 |
8,791,504 |
8,802,884 |
RGD:6480464 |
CTD |
| G |
Slc7a3 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
|
decreases expression |
ISO |
X |
89,159,603 |
89,164,314 |
RGD:6480464 |
CTD |
| G |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
|
decreases expression |
ISO |
5 |
5,446,597 |
5,571,661 |
RGD:6480464 |
CTD |
| G |
Snip1 |
Smad nuclear interacting protein 1 |
|
decreases expression |
ISO |
5 |
144,409,078 |
144,416,987 |
RGD:6480464 |
CTD |
| G |
Socs4 |
suppressor of cytokine signaling 4 |
|
decreases expression |
ISO |
15 |
23,229,083 |
23,243,568 |
RGD:6480464 |
CTD |
| G |
Spata13 |
spermatogenesis associated 13 |
|
increases expression |
ISO |
15 |
39,722,469 |
39,849,214 |
RGD:6480464 |
CTD |
| G |
Spata20 |
spermatogenesis associated 20 |
|
decreases expression |
ISO |
10 |
83,117,661 |
83,124,501 |
RGD:6480464 |
CTD |
| G |
Sptlc1 |
serine palmitoyltransferase, long chain base subunit 1 |
|
increases expression |
ISO |
17 |
17,576,401 |
17,615,246 |
RGD:6480464 |
CTD |
| G |
Stard8 |
StAR-related lipid transfer (START) domain containing 8 |
|
decreases expression |
ISO |
X |
87,088,565 |
87,102,511 |
RGD:6480464 |
CTD |
| G |
Syde1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
|
decreases expression |
ISO |
7 |
12,586,155 |
12,592,141 |
RGD:6480464 |
CTD |
| G |
Sympk |
symplekin |
|
decreases expression |
ISO |
1 |
78,377,890 |
78,407,581 |
RGD:6480464 |
CTD |
| G |
Tal1 |
T-cell acute lymphocytic leukemia 1 |
|
decreases expression |
ISO |
5 |
135,430,985 |
135,444,692 |
RGD:6480464 |
CTD |
| G |
Tardbp |
TAR DNA binding protein |
|
increases expression |
ISO |
5 |
165,698,665 |
165,709,531 |
RGD:6480464 |
CTD |
| G |
Tcf12 |
transcription factor 12 |
|
increases expression |
ISO |
8 |
76,311,327 |
76,498,091 |
RGD:6480464 |
CTD |
| G |
Tes |
testis derived transcript |
|
increases expression |
ISO |
4 |
42,680,722 |
42,719,246 |
RGD:6480464 |
CTD |
| G |
Tex13b |
testis expressed 13B |
|
decreases expression |
ISO |
X |
128,633,175 |
128,636,017 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tll1 |
tolloid-like 1 |
|
decreases expression |
ISO |
16 |
28,433,106 |
28,641,870 |
RGD:6480464 |
CTD |
| G |
Tmem59l |
transmembrane protein 59-like |
|
decreases expression |
ISO |
16 |
19,448,403 |
19,452,133 |
RGD:6480464 |
CTD |
| G |
Tor4a |
torsin family 4, member A |
|
decreases expression |
ISO |
3 |
3,353,628 |
3,357,315 |
RGD:6480464 |
CTD |
| G |
Tram2 |
translocation associated membrane protein 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Treh |
trehalase (brush-border membrane glycoprotein) |
|
decreases expression |
ISO |
8 |
47,631,777 |
47,645,166 |
RGD:6480464 |
CTD |
| G |
Tsc1 |
tuberous sclerosis 1 |
|
increases expression |
ISO |
3 |
7,645,313 |
7,672,944 |
RGD:6480464 |
CTD |
| G |
Tsc22d2 |
TSC22 domain family, member 2 |
|
decreases expression |
ISO |
2 |
147,754,030 |
147,799,940 |
RGD:6480464 |
CTD |
| G |
Ttc18 |
tetratricopeptide repeat domain 18 |
|
decreases expression |
ISO |
15 |
4,079,765 |
4,112,202 |
RGD:6480464 |
CTD |
| G |
Ttc22 |
tetratricopeptide repeat domain 22 |
|
decreases expression |
ISO |
5 |
127,700,123 |
127,716,927 |
RGD:6480464 |
CTD |
| G |
Tulp3 |
tubby-like protein 3 |
|
decreases expression |
ISO |
4 |
165,334,192 |
165,376,105 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
decreases expression |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
decreases activity |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Ube2d4 |
ubiquitin-conjugating enzyme E2D 4 (putative) |
|
decreases expression |
ISO |
14 |
2,469,772 |
2,471,246 |
RGD:6480464 |
CTD |
| G |
Ube2d4l1 |
ubiquitin-conjugating enzyme E2D 4 like 1 |
|
decreases expression |
ISO |
X |
100,805,532 |
100,807,116 |
RGD:6480464 |
CTD |
| G |
Ube2m |
ubiquitin-conjugating enzyme E2M |
|
decreases expression |
ISO |
1 |
72,885,667 |
72,889,204 |
RGD:6480464 |
CTD |
| G |
Ubqln1 |
ubiquilin 1 |
|
increases expression |
ISO |
17 |
12,370,389 |
12,418,868 |
RGD:6480464 |
CTD |
| G |
Usp44 |
ubiquitin specific peptidase 44 |
|
decreases expression |
ISO |
7 |
30,898,472 |
30,971,342 |
RGD:6480464 |
CTD |
| G |
Vps13b |
vacuolar protein sorting 13 homolog B (yeast) |
|
decreases expression |
ISO |
7 |
70,839,616 |
71,464,951 |
RGD:6480464 |
CTD |
| G |
Vps39 |
vacuolar protein sorting 39 homolog (S. cerevisiae) |
|
increases expression |
ISO |
3 |
106,803,136 |
106,842,405 |
RGD:6480464 |
CTD |
| G |
Vwa3a |
von Willebrand factor A domain containing 3A |
|
decreases expression |
ISO |
1 |
179,585,656 |
179,634,495 |
RGD:6480464 |
CTD |
| G |
Wdr63 |
WD repeat domain 63 |
|
decreases expression |
ISO |
2 |
244,217,428 |
244,276,489 |
RGD:6480464 |
CTD |
| G |
Wnt10a |
wingless-type MMTV integration site family, member 10A |
|
decreases expression |
ISO |
9 |
74,124,403 |
74,137,508 |
RGD:6480464 |
CTD |
| G |
Zbtb20 |
zinc finger and BTB domain containing 20 |
|
increases expression |
ISO |
11 |
58,662,837 |
59,399,213 |
RGD:6480464 |
CTD |
| G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
|
decreases expression |
ISO |
2 |
181,576,165 |
181,578,156 |
RGD:6480464 |
CTD |
| G |
Zdhhc2 |
zinc finger, DHHC-type containing 2 |
|
decreases expression |
ISO |
16 |
55,155,221 |
55,225,216 |
RGD:6480464 |
CTD |
| G |
Zfp141 |
zinc finger protein 141 |
|
decreases expression |
ISO |
1 |
93,011,706 |
93,026,296 |
RGD:6480464 |
CTD |
| G |
Zfp167 |
zinc finger protein 167 |
|
decreases expression |
ISO |
8 |
127,591,874 |
127,625,629 |
RGD:6480464 |
CTD |
| G |
Zfp354b |
zinc finger protein 354B |
|
decreases expression |
ISO |
10 |
36,489,415 |
36,499,335 |
RGD:6480464 |
CTD |
| G |
Zfp414 |
zinc finger protein 414 |
|
decreases expression |
ISO |
7 |
16,131,618 |
16,134,227 |
RGD:6480464 |
CTD |
| G |
Zfp483 |
zinc finger protein 483 |
|
decreases expression |
ISO |
5 |
76,990,071 |
77,003,107 |
RGD:6480464 |
CTD |
| G |
Zp2 |
zona pellucida glycoprotein 2 (sperm receptor) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
monobenzone
|
| G |
Afp |
alpha-fetoprotein |
|
affects binding |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
tetrachlorohydroquinone
|
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Cse1l |
CSE1 chromosome segregation 1-like (yeast) |
|
decreases expression |
ISO |
3 |
158,061,678 |
158,100,065 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects binding |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
Term paths to the root
|